CELLutions Biosystems

About CELLutions Biosystems

CELLutions Biosystems Inc. operates as a brand and division of Cedarlane, a Canadian corporation specializing in life science research products. Originally founded by the University of Toronto Innovations Foundation, CELLutions was acquired by Cedarlane in November 2007. The company's primary focus is the commercialization of highly characterized and novel cell lines, particularly neuronal cell lines, used to investigate diseases and screen for potential therapeutic targets.

The products are utilized by academic and commercial research programs. The core offerings include various cell line platforms such as Hypothalamic, Motor Neuron, and Oligodendrocytic cell lines. Beyond cell lines, the company has also developed a core competency in commercializing enzymes and molecular biology reagents. CELLutions aims to provide research products that can have a significant impact on a variety of research initiatives.

As part of Cedarlane, which was founded in 1957 and incorporated in 1975, CELLutions benefits from a well-established global distribution network. Cedarlane itself manufactures a range of biologicals, including monoclonal and polyclonal antibodies and cell separation media, while also distributing over two million products from more than 1,400 global suppliers to a customer base of approximately 20,000 life science researchers. This structure provides freight consolidation and cost-saving advantages to its clients. The parent company operates with ISO 9001 and ISO 13485 certifications, underscoring a commitment to quality management.